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Available online 26 September 2015Induced pluripotent stem (iPS) cells are generated frommouse and human somatic cells by forced expression of
deﬁned transcription factors using different methods. Amniotic ﬂuid (AF) cells are easy to obtain from routinely
scheduled procedures for prenatal diagnosis and iPS cells have been generated from human AF. Here, we gener-
ated iPS cells frommouse AF cells, using a non-viral-based approach constituted by the PiggyBac (PB) transposon
system. All iPS cell lines obtained exhibited characteristics of pluripotent cells, including the ability to differenti-
ate toward derivatives of all three germ layers in vitro and in vivo.
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Up tonow, humanamnioticﬂuid stemcells have been reprogrammed
without ectopic factors (Moschidou et al., 2012). Herein, we established
the reprogramming of mouse AF cells through a protocol that involves
the use of a non-viral method, the PB system. AF was collected from foe-
tuses, at embryonic days 13.5, obtained from Oct4GFP mice, useful to).
. This is an open access article undermonitor the expression of the endogenous Oct4 in reprogrammed cells.
The samemethod has been used to reprogram AF cells frommice consti-
tutively expressing GFP. Mouse AF cells were transfected with circular
PB-tetO2-IRES-OKMS, which expresses the Yamanaka factors linked to
mCherry ﬂuorescent protein in a doxycycline-inducible manner,
(Fig. 1A and (Woltjen et al., 2015)) and reverse tetracycline transactivator
(rtTA) plasmid in conjunction with the PB transposase expression plas-
mid (mPBase) (Woltjen et al., 2009). The transfection of mouse cells
was performed after 1 week of in vitro expansion over a MEF feeder
layer according to the protocol described in Fig. 1B, in two separate ex-
periments. Cells were maintained in culture, without passaging, in the
presence of doxycycline at the concentration of 1.5 μg/ml. The ﬁrst PB-
tetO2-OKMS-induced colonies depicting an ES-like morphology ap-
peared 20 days after doxycycline induction. They were picked 30 days
post-transfection and seeded on inactivated feeder layer. After isolation,
surviving clones were maintained in medium supplemented with doxy-
cycline for a few passages until they became doxycycline-independent
(3 out of 54 = 5% for Oct4GFP, 4 out of 30 = 13% for constitutive GFP)
in replicatewells, as shown in Fig. 1C. The tested clones proved to be pos-
itive for the alkaline phosphatase and for the pluripotency markers Oct4,
Sox2 and Nanog (Fig. 1D). The same pluripotency marker expressions
were evaluated in miPS-AF-GFP (Fig. 1E). iPS cells were also tested for
the expression of endogenous and exogenous pluripotency genes
(Fig. 1F): as expected, all the endogenous genes Oct4, Klf4, Myc and
Sox2 were activated in the iPS cell clones whereas the corresponding
exogenous genes, deﬁned as transgene (Tg), were expressed in the
presence of doxycycline and down regulated or completely silenced
when cultured without doxycycline. To evaluate the capacity of iPS cell
clones to differentiate into cells belonging to the three germ layers, cells
underwent EBs differentiation and after 21 days they resultedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.mIPS-AF-Oct4GFP/GFP generated by PB-mediated factor transposition. A) The PB-TET transposon vector used to deliver inducible (tetO), reporter-linked (IRES-mCherry) mouse
factors (OKMS). 3′/5′ TR, PB terminal repeats; B1/B2, post-Gateway cloning sites. B) Mouse AF cells were plated on a feeder layer of mitotically inactivated MEF in ES medium, and
transfected using Fugene (day 0) with PB-tetO2-IRES-OKMS, PB-rtTA and mPBase. Expression of 4 factors was achieved by adding doxycycline in culture (day 1), 24 h after transfection.
Colonies emerged 20 days post-transfection and they were picked on day 30 and transferred to feeder layers in ES medium with/without doxycycline. C) Reprogrammed clones were
screened for mCherry and Oct4 expression and alkaline phosphatase (ALP) activity, to determine general transgene activity in the presence and absence of doxycycline. mCherry was
expressed only in the presence of doxycycline and Oct4GFP appears in the absence of doxycycline. Scale bar = 100 μm. D–E) Stable doxycycline-independent miPS-AF-Oct4GFP/GFP
expressed Oct4, Sox2, Nanog, Klf4 and SSEA1. Scale bar = 100 μm. F) RT-PCR analysis for the expression of exogenous (vector-based primers, Tg) and endogenous (Oct4, Klf4,Myc and
Sox2) genes. β2microglobulin (B2m) was considered as housekeeping gene. Reprogrammed cell lines (Oct4GFP and GFP) were grown in the presence (+) or absence (−) (96 h) of doxy-
cycline. R1 ES cells were used as control.
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(endoderm) and Tubb3 (ectoderm), as showed in Fig. 2A,D. We also
injected iPS cells into immunocompromised mice, and after 6 weeks tu-
mour masses arose (Fig. 2B). Teratomas were processed, analysed and
tissues belonging to the three germ layers were found as showed by
the haematoxylin and eosin staining (Fig. 2D) and by the positivity for
the differentiation markers (Fig. 2C,D). These demonstrated that miPS-
AF-(Oct4GFP/GFP) possessed the ability to differentiate into cells belong-
ing to tissues of the three germ layers.
2. Materials and methods
2.1. Cell isolation and culture
All procedures were in accordance with Canadian and Italian law
(Prot. N. 56322). Embryo age was deﬁned relative to themorning of vag-
inal plug discovery (E0.5). All dissectionswere performed under a stereo-
microscope (Leica Microsystems). Amniotic ﬂuid (AF) samples were
harvested from pregnant mice at embryonic days 13.5 (Piccoli et al.,
2012) from CD1-Tg(Pou5f1-EGFP) named as Oct4GFP and C57BL/6-Tg(UBC-GFP)30Scha/J mice (Jackson) named as GFP. Freshly isolated AF
cells were plated onto a feeder layer of mitomycin C-treated MEFs in
DMEM (Invitrogen) supplemented with 15% ES FBS (Invitrogen),
100 mM non-essential amino acids (Invitrogen), 2 mM L-glutamine
(Sigma), 50 units/ml penicillin (Sigma), 50 mg/ml streptomycin
(Sigma), 0.01 mM 2-mercaptoethanol (Sigma) and 20 ng/ml LIF
(Sigma). Cells were cultivated at 37 °C and 5% CO2.
2.2. PB production
PiggyBac (PB) expression vectors were generated using standard
cloning procedures. The plasmid DNA for mouse AF transfection was
prepared using a QIAprep SpinMiniprep Kit andMaxiprep Kit (Qiagen).
2.3. Transfection, iPS cell generation and culture
Mouse AF cells were expanded as described in cell isolation and cul-
ture, and transfected after 7 days of culture,with the Yamanaka's factors
(Oct4, Klf4, Myc, Sox2) (Takahashi and Yamanaka, 2006). Factors were
fused in-frame into a single open reading frame (ORFs) linked with 2A
Fig. 2. In vitro and in vivo differentiation potential of miPS-AF-Oct4GFP/GFP. A) EBs obtained frommiPS-AF-Oct4GFP, after 21 days of differentiation, resulted positive for the expression of
brachyury (T, mesoderm),αfetoprotein (Afp, endoderm) and βIIItubulin (Tubb3, ectoderm). Scale bar= 100 μm. B)Macroscopic aspect of Rag2−/−γc−/−mouse hind limbs and tumour.
Post intramuscular injection of miPS-AF-Oct4GFP animals were sacriﬁced after 6 weeks. C) RT-PCR analysis of EBs and two teratoma samples (T1 from miPS-AF-Oct4GFP and T2 from
miPS-AF-GFP). C+, positive control; NTC, non-template control. D) Teratomas histology and immunostaining conﬁrmed cell differentiation into all three germ layers (mesoderm, endo-
derm and ectoderm). Alpha smooth muscle actin (αSMA, mesoderm), αfetoprotein (Afp, endoderm) and βIIItubulin (Tubb3, ectoderm) were expressed in tumour masses. Scale bar =
100 μm.
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tetO2-IRES-OKMS) under the transcriptional control of the tetO2 tetra-
cycline/doxycycline inducible promoter (Woltjen et al., 2015). All was
linked to amCherry ﬂuorescent protein gene through an IRES sequence.
Cells were transfected with the PB-tetO2-IRES-OKMS transposon plas-
mid, in conjunctionwith a PB transposase expression plasmid (mPBase)
andwith the reverse tetracycline transactivator (rtTA) transposon plas-
mid (PB-CAG-rtTA) (Woltjen et al., 2015). Fugene HD Transfection
Reagent (Promega) has been used, with a ratio of 1 μg of DNA: 4 μl of
Transfection Agent. The expression of the Yamanaka's factors was in-
ducedwith 1.5 μg/ml doxycycline (Sigma) the day after the transfection
(Woltjen et al., 2015; Woltjen et al., 2009). Twenty-four hours after
transfection, cellswere fedwith fresh ESmedia dailywithout passaging.
The resulting colonies were picked 30 days after transfection and iPS
clones were maintained on inactivated feeders in ES medium supple-
mented with LIF.
2.4. Alkaline phosphatase staining and immunoﬂuorescence
Alkaline phosphatase staining was carried out following the
manufacturer's instruction (Vector Red Alkaline Phosphatase Substrate
Kit I). Immunoﬂuorescence analyses were performed on cells using pri-
mary antibodies Oct4, Sox2, Klf4 (1:80, SantaCruz), Nanog (1:100,
ReproCELL) and SSEA1 (1:80, Abcam). Cells were ﬁxed with 4% parafor-
maldehyde (PFA) and permeabilised with 0.1% NP-40. Primary antibod-
ieswere diluted in 1% BSA, 10%NormalGoat Serum, 0.3MGlycine in 0.1%
PBS-Tween (all from Sigma) for SSEA1 and 10% Horse Serum in PBS 1XTable 1
RT-PCR primer list.
Gene Forward
β2microglobulin (B2m) CAGTTCAGTATGTTCGGCTTCC
Transgene (Tg) CCAATCAGCTTGGGCTAGAG
Pou5f1 (Oct4) CCAACGAGAAGAGTATGAGGC
Klf4 GGCGAGAAACCTTACCACTGT
Myc TGCCCGCGATCAGCTCTCCT
Sox2 TCTGTGGTCAAGTCCGAGGC
Vimentin (Vim) CCAGAGACCCCAGCGCTCCT
βIIItubulin (Tubb3) TAGACCCCAGCGGCAACTAT
αfetoprotein (Afp) GCTGTGGTGAGGGAATGGCCGfor others, and incubated overnight at 4 °C. Secondary antibodies were
Alexa594-conjugated goat anti-mouse IgG (1:200), Alexa594-
conjugated chicken anti-goat IgG (1:200), Alexa594-conjugated chicken
anti-rabbit IgG (1:200), Alexa568-conjugated goat anti-mouse IgM
(1:200) (all from Life Technologies). Nuclei were stained with Hoechst
solution in PBS 1X (Life Technologies). Cells were observed under
inverted immunoﬂuorescence microscope (Leica DMI6000B, Leica
Microsystems).
2.5. Reverse transcription-polymerase chain reaction analysis
RNA was isolated using TRIzol reagent (Life Technologies) and
RNeasyMini Kit (Qiagen) according to themanufacturer's recommend-
ed protocol. First-strand cDNA was synthesized using the Superscript
Reverse Transcriptase II and related products (all from Life Technolo-
gies). The cDNA was diluted with RNase-free water at a concentration
of 10 ng/ml. RT-PCR was performed using the Taq DNA Polymerase
(Life Technologies). Primers used are listed in Table 1.
2.6. In vitro differentiation
ES cells were cultured in hanging drops (1000/2000 cells for each
drop) to form embryoid bodies (EBs) in differentiation medium consti-
tuted by DMEM (Invitrogen) supplemented with 15% ES FBS
(Invitrogen), 100 mM non-essential amino acids (Invitrogen),
2 mM L-glutamine (Sigma), 50 units/ml penicillin (Sigma), 50 mg/ml
streptomycin (Sigma), 0.01 mM 2-mercaptoethanol (Sigma), forReverse Annealing temperature
GCTTCAGTCGTCAGCATGG 57 °C
GTGGGTTAGCGAGTTGGAAA 58 °C
CAAAATGATGAGTGACAGACAGG 62 °C
TACTGAACTCTCTCTCCTGGCA 60 °C
CGTGGCTGTCTGCGGGGTTT 60 °C
TTCTCCAGTTCGCAGTCCAG 60 °C
GCCGGAGCCACCGAACATCC 57 °C
GTTCCAGGTTCCAAGTCCACC 60 °C
ACGAAGAGTTGCAGCAGTGGCT 58 °C
513E. Bertin et al. / Stem Cell Research 15 (2015) 510–5134 days. EBs were then transferred into a 100 mmbacterial-grade dishes
in suspension culture for 3 days in differentiation medium. EBs where
then plated in 24 wells plates coated with matrigel for other 14 days.
Immunoﬂuorescence analyses were performed using as primary anti-
bodies T (1:100, Abcam), Afp (1:200, R&D Systems) and Tubb3
(1:500, Promega Italia). Cells were observed under inverted immuno-
ﬂuorescence microscope (Leica DMI6000B, Leica Microsystems).
2.7. Teratoma assay and analysis
For teratoma assay, about 1 × 106 iPS-AF cells were injected into the
muscle of the hindlimb of Rag2−/−γc−/− mice. After 6 weeks, mice
were sacriﬁced and tumours collected for following analyses. Trans-
verse sections (7–10 μm thick) of isopentan-frozen muscles were
stained with haematoxylin and eosin to evaluate the tumour tissue
composition. For immunoperoxidase staining, teratoma sections were
ﬁxed using 4% PFA and permeabilized with 0.1% triton X-100. Tubb3
(1:100, Promega Italia), Afp (1:50, R&D Systems) and αSMA (1:100,
Abcam) primary antibodies were diluted in 1% BSA in PBS 1X and
incubated for 1 h at 37 °C (for Tubb3) or overnight at 4 °C (for others).
After peroxidase blocking, secondary antibody HRP-conjugated was in-
cubated for 45 min at 37 °C. After incubation with ImmPACT NovaRED
(Vector Laboratories) for 5 min, cytoplasm was stained with
Haematoxylin (Vector Laboratories) for 9 s. Sections were observed by
Olympus BX60microscope (Olympus). Pictureswere taken using View-
Finder Lite software.
3. Veriﬁcation and authentication
To conﬁrm iPS cell identity and purity, we showed the positivity for
the alkaline phosphatase and for the expression of pluripotency
markers both by immunoﬂuorescence and by RT-PCR (Fig. 1C-F).Acknowledgements
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